NASH prevalence is on the rise, but research focusing on the central role of liver health offers hope for the future1

Ongoing research centers on the rising prevalence of NASH with fibrosis and need for effective management options1,2

Stay informed as the NASH conversation evolves.

Sign up to receive emails for new information on NASH with fibrosis.

All fields are required.

By clicking "Subscribe" you certify that you are 18 years of age or older.

By providing your information, you consent to receiving marketing and promotional communications and other information from Madrigal Pharmaceuticals. You hereby give consent to Madrigal, its affiliates, and their agents and representatives to send communications and information to you via the contact information you have provided above. This consent will be in effect until such a time as you opt out of communications from Madrigal.